Alternatively, enhancing the probability of IL-27p28 binding with EBI3 to yield IL-27 would increase the abundance of IL-27 in the TME, while decreasing the availability of IL-30, further promoting IL-27 mediated anti-tumor immunity. The gene discussed is IL27; the disease is neoplasm.